Mad in America: Rethinking Mental Health
Health & Fitness:Mental Health
Swapnil Gupta is an Associate Professor and Medical Director of Ambulatory Psychiatry at Mount Sinai Morningside Hospital. She was trained as a psychiatrist in India and the United States, at SUNY Downstate Medical Center and Yale University, and PGI Chandigarh in India. She is known for her work on deprescribing from and discontinuation of psychiatric drugs.
Dr. Gupta’s career began with research on the role of the endocannabinoid system in the pathophysiology of schizophrenia as an academic psychiatrist. Her subsequent scholarship has focused on applying deprescribing, the systematic reduction of unnecessary medications, to psychiatry by rooting it in the principles of recovery-oriented care. She has authored several peer-reviewed papers on deprescribing and co-authored a book with Rebecca Miller and John Cahill.
She is an active member of two organizations that aim to enhance stakeholder engagement in psychiatric research. She is also a part of the editorial board of the Community Mental Health Journal. Currently, she is working on creating educational resources to help people discontinue psychiatric medications and gathering information on the knowledge and opinions of psychiatrists regarding the discontinuation of such drugs.
In this interview, we discuss deprescribing from psychiatric drugs, the difficult decisions faced by patients, the importance of psychosocial support during withdrawal, and how deprescribing is central to recovery-oriented practices such as shared decision and patient choice. We will also tackle the complex issue of whether the recurrence of symptoms once a drug is tapered is a mark of relapse or withdrawal caused by the psychiatric medication.
***
Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.
To find the Mad in America podcast on your preferred podcast player, click here
Context and Care vs Isolate and Control - An Interview with Arthur Kleinman
Undisclosed Financial Conflicts of Interest in the DSM-5: An interview with Lisa Cosgrove and Brian Piper
Is Madness an Evolved Signal? – Justin Garson on Strategy Versus Dysfunction
'It Was a Joint Effort'- Deborah Kasdan on Bringing Her Late Sister's Story to Life
What if Much of What you Thought you Knew About Mental Health was up for Debate?
The Psychological Humanities Manifesto: An Interview with Mark Freeman
Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs
Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric History
The Making of a 'Madness' That Hides Our Monsters - An Interview with Audrey Clare Farley
A Playground for Predators-Diane Dimond on The Abuses of Guardianship
May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem
Branding Diseases: Ray Moynihan on How Drug Companies Market Psychiatric Conditions
How Mad Studies and the Psychological Humanities are Changing Mental Health: An Interview with Narrative Psychiatrist Bradley Lewis
Embracing the Shadow—Charlie Morley on Lucid Dreaming as Therapy
Family Panel Discussion – Supporting a Child, Teen, or Young Person in Crisis
Sacred Conversations: A Talk with Susan Swim and a Father Whose Daughter Found Healing
The Radical Politics of Madness-Micha Frazer-Carroll
Can Psychosocial Disability Decolonize Mental Health? A Conversation with Luis Arroyo and Justin Karter
Sarah Fay - Cured: A Memoir
Create your
podcast in
minutes
It is Free
Mental Health Insights
MQ Open Mind
Speaking of Suicide
The Suicide Prevention Movement
Depression Talks Podcast